Advertisement
Advertisement
OGN
Organon & Co.
13.42
USDSponsored
0.00
0.00%
May 19, 15:59 UTC -4
Closed
After-Market
13.43
+0.01
+0.07%
OGN Earnings Reports
Positive Surprise Ratio
OGN beat 15 of 21 last estimates.
71%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.58B
/$0.92
Implied change from Q1 26 (Revenue/ EPS)
+8.34%
/+29.58%
Implied change from Q2 25 (Revenue/ EPS)
-0.77%
/-8.00%
Organon & Co. earnings per share and revenue
On Apr 30, 2026, OGN reported earnings of 0.71 USD per share (EPS) for Q1 26, missing the estimate of 0.83 USD, resulting in a -15.23% surprise. Revenue reached 1.46 billion, compared to an expected 1.50 billion, with a -2.61% difference. The market reacted with a -0.67% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of 0.92 USD, with revenue projected to reach 1.58 billion USD, implying an increase of 29.58% EPS, and increase of 8.34% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enhabit, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
$0.15
Actual
-Surprise
-
COMPASS Pathways Plc - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.38
Actual
-$0.30
Surprise
+22.20%
SBC Medical Group Holdings Incorporated Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.09
Actual
$0.11
Surprise
+11.11%
Forward Industries, Inc. Common Stock
Report Date
May 14, 2026 For Q2 26
Estimate
-$0.03
Actual
$0.04
Surprise
+230.72%
Shoulder Innovations, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.42
Actual
-$0.41
Surprise
+3.10%
Park Dental Partners, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
$0.20
Actual
$0.44
Surprise
+115.69%
SeaStar Medical Holding Corporation Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.83
Actual
-$0.90
Surprise
-8.00%
Lifeward Ltd. Ordinary Shares
Report Date
May 15, 2026 For Q1 26
Estimate
-$1.28
Actual
-$3.63
Surprise
-183.57%
Aclarion, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$1.58
Actual
-$1.34
Surprise
+15.24%
Synergy CHC Corp. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.03
Actual
-$0.23
Surprise
-744.26%
FAQ
What were Organon & Co.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Organon & Co. reported EPS of $0.71, missing estimates by -15.23%, and revenue of $1.46B, -2.61% below expectations.
How did the market react to Organon & Co.'s Q1 2026 earnings?
The stock price moved down -0.67%, changed from $13.34 before the earnings release to $13.25 the day after.
When is Organon & Co. expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Organon & Co.'s next earnings report?
Based on 4
analysts, Organon & Co. is expected to report EPS of $0.92 and revenue of $1.58B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement